openPR Logo
Press release

Drug for Abuse Testing Devices Industry Insights by Size, Trends, Outlook, and Opportunity Till 2026

09-04-2018 01:26 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Drug for Abuse Testing Devices Market Growth Analysis

Drug for Abuse Testing Devices Market Growth Analysis

Drugs for abuse testing device offer testing methods to detect drugs present in the human body by analyzing saliva, blood, urine, and sweat. The drug for abuse testing devices market comprises kits and devices, which help in measuring drug intake. Tests can be conducted at home as well as in laboratories. The test uses immunoassay to screen different samples and includes the confirmation of screening results by definitive analytical techniques such as spectrometry and chromatography.

Drugs such as cocaine, heroin, diazepam, methamphetamine, marijuana, lorazepam, anabolic steroids, and inhalants tend to cause addiction, health problems, and severe illness in adults. Several anti-doping agencies use drugs for abuse testing device to measure the steroids consumed by athletes.

Download PDF Brochure Of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/718
Rise in drug abuse is expected to ensure swift uptake of drug testing products

According to the United Nations Office on Drugs and Crime (UNODC), 246 million people in the age group of 15 to 64 years used illicit drugs in 2013 globally. Also, according to the National Survey on Drug Use and Health in 2014, 9.8 million adults across the globe suffered from serious mental illness owing to the high use of drugs. The market is expected to witness a prolific growth due to the increasing abuse of illicit drugs, alcohol, and tobacco.

The rise in workplace screening around the globe to ensure safe working environment devoid of illicit activities of the employees is driving the drug for abuse testing devices market. Also, the growing number of initiatives taken by the governments along with nonprofit organizations to reduce the levels of drug abuse is expected to have a positive impact on the global market.
Demand for breath analyzers is expected to fuel the global drug for abuse testing devices market

Get Best Discount Before Buying Research Report: https://www.coherentmarketinsights.com/insight/request-discount/718

The global drug for abuse testing devices market is segmented on the basis of device type, testing, end user, and geography.

On the basis of device type, the global drugs for abuse testing devices market is segmented into:
• Immunoassay analyzers
• Chromatography instruments
• Breath analyzers
On the basis of testing, the global market is segmented into:
• Breath
• Urine
• Blood
• Others
On the basis of end user, the global market is segmented into:
• Hospitals
• Diagnostics Laboratories
• Forensic Laboratories
• Drug rehabilitation centers
• Government and private departments

Increasing prevalence of chronic diseases and stringent government norms to boost North America market

Latest innovations in the drugs for abuse testing market offer high sensitivity

Key players operating in the drugs for abuse testing device market are Alere, Inc., Drägerwerk, Thermo Fisher Scientific, Siemens Healthineers Inc. QuikScreen Multi 12 drug test cup is an in-vitro diagnostic assay, which employs a mixture of antibodies for selective identification of drugs of abuse in the test samples with a high degree of sensitivity. Other leading vendors in the market are Express Diagnostics International, Inc., F. Hoffmann La-Roche Ltd., Shimadzu Corporation, and Laboratory Corporation of America Holdings.

Request For Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/718

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug for Abuse Testing Devices Industry Insights by Size, Trends, Outlook, and Opportunity Till 2026 here

News-ID: 1219042 • Views:

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 2026 : Key Players are Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2026
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Research Report 2018-2026
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insignificant CAGR Till 2025 With Top Players Novartis AG, Celgene Corp, Otsuka Pharmaceutical Co., Sandoz, Dr Reddys Laboratories, Pharmascience
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug